Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Korro Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 49 | 64 | +15 |
| Shares | 6.91M | 8.44M | +1.53M (+22.1%) |
| Value | $618.6M | $285.7M | −$332.9M (−53.8%) |
New holders (26)
Institutions that held Korro Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (11)
Institutions that held Korro Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Suvretta Capital Management, LLC | 73,821 | $6.64M |
| Invesco Ltd. | 72,419 | $6.52M |
| Monashee Investment Management LLC | 55,364 | $4.98M |
| Jane Street Group, LLC | 25,814 | $2.32M |
| Susquehanna International Group, LLP | 11,276 | $1.01M |
| Renaissance Technologies LLC | 9,893 | $890.0K |
| Balyasny Asset Management LLC | 3,773 | $339.6K |
| Brevan Howard Capital Management LP | 3,602 | $324.2K |
| Tower Research Capital LLC (TRC) | 50 | $4.50K |
| CWM, LLC | 6 | $1.00K |
| Macquarie Group Ltd | 389 | $35 |